Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells

Biochemical and Biophysical Research Communications

Volumn 373, Issue 1, 2008, Pages 80-84

  Moulédous, Lionel ^a   Merker, Soren ^a   Neasta, Jérémie ^a   Roux, Benoit ^a   Zajac, Jean Marie ^a   Mollereau, Catherine ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Cholesterol; Lipid rafts; Membrane fractionation; Neuropeptide FF; Opioid

Indexed keywords

CHOLESTEROL; DETERGENT; METHYL BETA CYCLODEXTRIN; MU OPIATE RECEPTOR; NEUROPEPTIDE FF; PROTEIN 1DME; REGULATOR PROTEIN;

ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION;

CELL FRACTIONATION; CELL LINE; DETERGENTS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMANS; MEMBRANE MICRODOMAINS; OLIGOPEPTIDES; RECEPTORS, NEUROPEPTIDE; RECEPTORS, OPIOID, MU;

EID: 45849091111     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.174     Document Type: Article

References (33)

1. Panula P., Aarnisalo A.A., and Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48 (1996) 461-487
2. Roumy M., and Zajac J.M. Neuropeptide FF, pain and analgesia. Eur. J. Pharmacol. 345 (1998) 1-11
3. Fukusumi S., Fujii R., and Hinuma S. Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 27 (2006) 1073-1086
4. Zajac J.M. Neuropeptide FF: new molecular insights. Trends Pharmacol. Sci. 22 (2001) 63
5. Mollereau C., Roumy M., and Zajac J.M. Opioid-modulating peptides: mechanisms of action. Curr. Top. Med. Chem. 5 (2005) 341-355
6. Mollereau C., Mazarguil H., Zajac J.M., and Roumy M. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol. 67 (2005) 965-975
7. Roumy M., Lorenzo C., Mazeres S., Bouchet S., Zajac J.M., and Mollereau C. Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J. Biol. Chem. 282 (2007) 8332-8342
8. Insel P.A., Head B.P., Patel H.H., Roth D.M., Bundey R.A., and Swaney J.S. Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae. Biochem. Soc. Trans. 33 (2005) 1131-1134
9. Maekawa S., Iino S., and Miyata S. Molecular characterization of the detergent-insoluble cholesterol-rich membrane microdomain (raft) of the central nervous system. Biochim. Biophys. Acta 1610 (2003) 261-270
10. Bari M., Battista N., Fezza F., Finazzi-Agro A., and Maccarrone M. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 280 (2005) 12212-12220
11. Savi P., Zachayus J.L., Delesque-Touchard N., Labouret C., Herve C., Uzabiaga M.F., Pereillo J.M., Culouscou J.M., Bono F., Ferrara P., and Herbert J.M. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc. Natl. Acad. Sci. USA 103 (2006) 11069-11074
12. Andre A., Gaibelet G., Le Guyader L., Welby M., Lopez A., and Lebrun C. Membrane partitioning of various delta-opioid receptor forms before and after agonist activations: The effect of cholesterol. Biochim. Biophys. Acta 1778 (2008) 1483-1492
13. Head B.P., Patel H.H., Roth D.M., Lai N.C., Niesman I.R., Farguhar M.G., and Insel P.A. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J. Biol. Chem. 280 (2005) 31036-31044
14. Huang P., Xu W., Yoon S.I., Chen C., Chong P.L., and Liu-Chen L.Y. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Biochem. Pharmacol. 73 (2007) 534-549
15. Huang P., Xu W., Yoon S.I., Chen C., Chong P.L., Unterwald E.M., and Liu-Chen L.Y. Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Brain Res. 1184 (2007) 46-56
16. Huang P., Chen C., Xu W., Yoon S.I., Unterwald E.M., Pintar J.E., Wang Y., Chong P.L., and Liu-Chen L.Y. Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor. Biochem. Biophys. Res. Commun. 365 (2008) 82-88
17. Patel H.H., Head B.P., Petersen H.N., Niesman I.R., Huang D., Gross G.J., Insel P.A., and Roth D.M. Protection of adult cardiac myocites from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H344-H350
18. Xu W., Yoon S.I., Huang P., Wang Y., Chen C., Chong P.L., and Liu-Chen L.Y. Localization of the kappa opioid receptor in lipid rafts. J. Pharmacol. Exp. Ther. 317 (2006) 1295-1306
19. Zhao H., Loh H.H., and Law P.Y. Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol. Pharmacol. 69 (2006) 1421-1432
20. Mouledous L., Neasta J., Uttenweiler-Joseph S., Stella A., Matondo M., Corbani M., Monsarrat B., and Meunier J.C. Long-term morphine treatment enhances proteasome-dependent degradation of G beta in human neuroblastoma SH-SY5Y cells: correlation with onset of adenylate cyclase sensitization. Mol. Pharmacol. 68 (2005) 467-476
21. Song K.S., Li S., Okamoto T., Quilliam L.A., Sargiacomo M., and Lisanti M.P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem. 271 (1996) 9690-9697
22. Brown D.A. Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 21 (2006) 430-439
23. Lagane B., Gaibelet G., Meilhoc E., Masson J.M., Cezanne L., and Lopez A. Role of sterols in modulating the human mu-opioid receptor function in Saccharomyces cerevisiae. J. Biol. Chem. 275 (2000) 33197-33200
24. Pike L.J., Han X., and Gross R.W. Epidermal growth factor receptors are localized to lipid rafts that contain a balance of inner and outer leaflet lipids: a shotgun lipidomics study. J. Biol. Chem. 280 (2005) 26796-26804
25. Ohira K., Maekawa S., and Hayashi M. Absence of TrkB and insulin receptor beta in the Triton insoluble low-density fraction (raft). Neuroreport 11 (2000) 1307-1311
26. Eckert G.P., Igbavboa U., Muller W.E., and Wood W.G. Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res. 962 (2003) 144-150
27. Sauliere A., Gaibelet G., Millot C., Mazeres S., Lopez A., and Salome L. Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH-SY5Y cells is restricted to permeable domains. FEBS Lett. 580 (2006) 5227-5231
28. Suzuki K., Ritchie K., Kajikawa E., Fujiwara T., and Kusumi A. Rapid hop diffusion of a G-protein-coupled receptor in the plasma membrane as revealed by single-molecule techniques. Biophys. J. 88 (2005) 3659-3680
29. Daumas F., Destainville N., Millot C., Lopez A., Dean D., and Salome L. Interprotein interactions are responsible for the confined diffusion of a G-protein-coupled receptor at the cell surface. Biochem. Soc. Trans. 31 (2003) 1001-1005
30. Mishra S., and Joshi P.G. Lipid raft heterogeneity: an enigma. J. Neurochem. 103 Suppl. 1 (2007) 135-142
31. Lichtenberg D., Goni F.M., and Heerklotz H. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem. Sci. 30 (2005) 430-436
32. Baker A., Sauliere A., Dumas F., Millot C., Mazeres S., Lopez A., and Salome L. Functional membrane diffusion of G-protein coupled receptors. Eur. Biophys. J. 36 (2007) 849-860
33. Jacobson K., Mouritsen O.G., and Anderson R.G. Lipid rafts: at a crossroad between cell biology and physics. Nat. Cell Biol. 9 (2007) 7-14